Printer Friendly

Articles from M2 Pharma (March 9, 2017)

1-32 out of 32 article(s)
Title Author Type Words
Abeona Therapeutics granted Orphan Drug Designation in the EU for EB-101 gene therapy. 241
Agile incurs higher net loss of USD5.2m for Q4 2016. Financial report 165
Allergan files sNDA with the US FDA for VRAYLAR treatment for schizophrenia in adults. 269
Amicus reveals commercial launch of Galafold in Italy for the Fabry community. 287
BeiGene (Hong Kong) to set up joint venture with Guangzhou GET Technology Development. 205
BeiGene to build biologics manufacturing facility in Guangzhou, China. 243
BerGenBio ASA and Merck & Co. partner for phase II combination lung cancer trials. 204
BioCryst Pharmaceuticals announces public offering of USD45.0m common stock. 155
Bioversys and Aptuit commence joint collaboration to identify and validate novel targets and molecules for Gram-negative bacteria. 153
Bristol-Myers Squibb elects Thomas J. Lynch as EVP & CSO. 211
Caldan Therapeutics names new chief executive officer. 170
Cambridge University launches new initiative to support 'world-leading industry-academia collaborations' in therapeutics. 273
Community Health Systems Pricing USD 2.2bn Notes Offering. 232
CooperGenomics Receives ISO 15189 Accreditation in United Kingdom Laboratories for Noninvasive Prenatal Testing. 132
Delhi High Court maintains restriction on Cipla's Unibrez. 231
Dunsire Named President, Chief Executive Officer at XTuit Pharmaceuticals. 250
emotive names Dr Gill Boucher as new medical director. 113
GSK hires Omongiade Ehighebolo as communications & government affairs director in West and Central Africa. 141
Immune Therapuetics teams up with Omaera, GB Pharma Holdings to bring life-saving AIDS drug to Kenya. 262
Innovus Pharma Receives CPNP Notification to Commercialize Sensum+ in the European Union. 266
Innovus Pharma to commercialise Sensum+ in the EU following the CPNP notification. 270
Novo Nordisk considering acquisition of Global Blood Therapeutics. 209
Parkinson's UK launches GBP1m virtual biotech company to create new treatments. 217
Perrigo reports final approval and OTC launch of new store foam brand equivalent to Women's Rogaine 5% minoxidil foam. 173
Spitzer Joins Innovaccer's Board of Advisors. 176
TG Therapeutics to launch public offering of common stock. 168
The European Commission grants marketing authorisation to Actelion's Ledaga. 172
The ICR calls on EMA to reform paediatric cancer trials regulations. 245
TiGenix announces topline data for Phase III Crohn's disease study. Clinical report 279
US FDA Accepts Alexion's sBLA Filing of Soliris as for Refractory Generalised Myasthenia Gravis. 315
Virta Health Launches to Reverse Type 2 Diabetes. 298
Warburg Pincus to Invest USD 115m in Alignment Healthcare. 221

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters